Clinical Trial Update: Gemtuzumab Ozogamicin, Fludarabine, and Total-body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome [Phase 2]

View source ↗

Summary

A phase 2 trial evaluating a conditioning regimen of gemtuzumab ozogamicin with fludarabine and total-body irradiation followed by stem cell transplantation in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Fludarabine (Fludarabine)
• Gemtuzumab ozogamicin (Mylotarg) (gemtuzumab ozogamicin)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Leukemia, Myelodysplastic Syndromes | Phase 2 | Status: COMPLETED